ストックスクリーナーアプリを入手
3.15
0.32%
-0.01
アフターアワーズ：
3.32
0.17
+5.40%
前日終値:
$3.16
開ける：
$3.16
24時間の取引高:
94,791
Relative Volume:
0.27
時価総額：
$38.37M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+3.96%
1か月 パフォーマンス:
-10.76%
6か月 パフォーマンス:
-92.14%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$3.08
$3.21
1週間の範囲:
$2.90
$3.46
52週間の値動き範囲:
$2.90
$53.79
Q 32 Bio Inc Stock (QTTB) Company Profile
QTTB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
QTTB
Q 32 Bio Inc
|
3.15 | 38.37M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.32 | 120.86B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
710.00 | 77.62B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
646.64 | 39.62B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
276.19 | 35.50B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.61 | 28.20B | 3.30B | -501.07M | 1.03B | -2.1146 |
Q 32 Bio Inc Stock (QTTB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-11 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-12-11 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-12-11 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2024-12-11 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | 開始されました | BMO Capital Markets | Outperform |
| 2024-10-24 | 開始されました | Raymond James | Strong Buy |
| 2024-09-11 | 開始されました | Wells Fargo | Overweight |
| 2024-06-17 | 開始されました | Guggenheim | Buy |
| 2024-05-21 | 開始されました | Leerink Partners | Outperform |
| 2024-04-11 | 開始されました | Oppenheimer | Outperform |
| 2024-04-02 | 開始されました | Piper Sandler | Overweight |
| 2023-07-28 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2022-02-22 | 繰り返されました | BTIG Research | Neutral |
| 2022-02-22 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-02-22 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-03-02 | 開始されました | Stifel | Hold |
| 2020-12-14 | 再開されました | H.C. Wainwright | Buy |
| 2020-08-11 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-25 | 再開されました | BofA/Merrill | Buy |
| 2020-05-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2020-03-16 | アップグレード | Oppenheimer | Perform → Outperform |
| 2020-02-24 | 開始されました | Chardan Capital Markets | Buy |
| 2019-11-01 | 開始されました | Oppenheimer | Perform |
| 2019-09-10 | 開始されました | Robert W. Baird | Outperform |
| 2019-04-12 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Q 32 Bio Inc (QTTB) 最新ニュース
Q32 Bio to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference - The Eastern Progress Online
QTTB stock touches 52-week low at $2.95 amid market challenges - MSN
Barclays PLC Acquires 5,353 Shares of Q32 Bio Inc. (NASDAQ:QTTB) - Defense World
Q32 Bio Inc. (NASDAQ:QTTB) Receives $29.86 Consensus Target Price from Brokerages - Defense World
Q32 Bio Advances Clinical Trials for Growth Opportunities - TipRanks
Pre-market Movers: ONCO, EYEN, SGMO, VSTM... - RTTNews
Q32 Bio Inc (QTTB) Could Be Worth Considering For The Next Few Weeks - Stocks Register
Arq Inc (ARQ) Analyst Thoughts: How High Can It Go? - Stocks Register
Analysts Update Their Estimates For Brunswick Corp - Stocks Register
At $1.81 Price, XCHG Ltd ADR (XCH) Is Sitting And Waiting - Stocks Register
Analysts Update Their Estimates For EPR Properties - Stocks Register
Protagenic Therapeutics Inc’s (PTIX) -12.44% Retreat Justifies A Second Look - Stocks Register
LegalZoom.com Inc (LZ) Volatility Hits 3.83% – Here Is What You Should Do - Stocks Register
At $18.67 Price, Osisko Gold Royalties Ltd (OR) Is Sitting And Waiting - Stocks Register
First Foundation Inc (FFWM): A New Perspective - Stocks Register
Analyst Updating Price Targets And Ratings For Springview Holdings Ltd (SPHL) - Stocks Register
QTTB Stock Touches 52-Week Low at $3 Amid Market Challenges - Investing.com India
QTTB Stock Touches 52-Week Low at $3 Amid Market Challenges By Investing.com - Investing.com South Africa
What You Didn’t Know About Chipotle Mexican Grill (NYSE: CMG) This Week - Stocks Register
Q32 Bio (QTTB) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Pre-market Movers: CDT, NARI, GDTC, NARI... - RTTNews
Geode Capital Management LLC Purchases 24,114 Shares of Q32 Bio Inc. (NASDAQ:QTTB) - Defense World
Jane Street Group LLC Acquires New Stake in Q32 Bio Inc. (NASDAQ:QTTB) - Defense World
Q32 Bio Inc. (NASDAQ:QTTB) Holdings Increased by Barclays PLC - Defense World
Franklin Resources Inc. Takes Position in Q32 Bio Inc. (NASDAQ:QTTB) - Defense World
NuScale Power Corporation (NYSE: SMR): An Enticing Stock To Watch - Stocks Register
Q32 Bio Inc. (NASDAQ:QTTB) Shares Bought by State Street Corp - Defense World
ARS Pharmaceuticals (NASDAQ:SPRY) vs. Q32 Bio (NASDAQ:QTTB) Head to Head Review - Defense World
Q32 Bio Inc. (NASDAQ:QTTB) Receives $29.86 Consensus Target Price from Analysts - Defense World
Here's Why Q32 Bio Stock Hit a New Record Low on Wednesday - MSN
Q32 Bio: Oppenheimer slashes price target on mixed trial results - MSN
Q32 Bio's SWOT analysis: stock outlook shifts amid clinical setbacks By Investing.com - Investing.com Canada
Q32 Bio's SWOT analysis: stock outlook shifts amid clinical setbacks - Investing.com India
Q32 Bio pushes back Phase 2 trial of ADX-097 in AAV patients - ANCA Vasculitis News
StockWatch: Q32 Shares Crater 85% as Investors, Analysts Sour on Trial Results - Genetic Engineering & Biotechnology News
BMO Capital Markets Cuts Q32 Bio (NASDAQ:QTTB) Price Target to $22.00 - Defense World
Q32 Bio FY2025 EPS Estimate Lifted by Leerink Partnrs - Defense World
FY2025 EPS Estimates for Q32 Bio Boosted by Leerink Partnrs - MarketBeat
Q32 Bio shares target cut, rating held on clinical trial results - Investing.com Canada
Here's Why Q32 Bio Stock Hit A New Record Low On Wednesday - Barchart
Q32 Bio (NASDAQ:QTTB) Rating Lowered to Hold at Leerink Partnrs - MarketBeat
Q32 Bio price target lowered to $20 from $80 at Oppenheimer - Yahoo Finance
Candel leads biotech gainers amid wave of data readouts - BioCentury
QTTB Stock Touches 52-Week Low at $8.06 Amid Market Volatility - Investing.com India
Leerink revises Q32 Bio stock target as Phase 2 trials fail to meet expectations - Investing.com Canada
Q32 Bio stock target cut, rating held on trial results By Investing.com - Investing.com Nigeria
Q32 Bio shares downgraded as Ph2 trials reveal limited near-term upside potential - Investing.com Nigeria
Q32 stock craters 71% on mixed Phase 2 data for bempikibart (NASDAQ:QTTB) - Seeking Alpha
Q32 Bio stock target cut, rating held on trial results - Investing.com
Oppenheimer maintains Outperform on Q32 Bio stock with focus on renal basket study - Investing.com
Why Is Skin Disease-Focused Q32 Bio Stock Trading Lower On Wednesday? - Benzinga
Q 32 Bio Inc (QTTB) 財務データ
Q 32 Bio Inc (QTTB) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Q 32 Bio Inc (QTTB) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Violette Shelia M. | Chief Scientific Officer |
Oct 11 '24 |
Option Exercise |
3.12 |
4,574 |
14,271 |
17,874 |
| Violette Shelia M. | Chief Scientific Officer |
Oct 08 '24 |
Option Exercise |
3.12 |
13,300 |
41,496 |
13,300 |
| TZIANABOS ARTHUR | Director |
Mar 25 '24 |
Sale |
24.20 |
265 |
6,413 |
7,983 |
| Alloway Paul | See Remarks |
Mar 25 '24 |
Sale |
24.21 |
268 |
6,488 |
2,596 |
| Michaud Charles Jr | See Remarks |
Mar 25 '24 |
Sale |
24.20 |
75 |
1,815 |
927 |
1.03%
大文字化:
|
ボリューム (24 時間):